DK2397136T3 - Antiinflammatorisk sammensætning - Google Patents

Antiinflammatorisk sammensætning Download PDF

Info

Publication number
DK2397136T3
DK2397136T3 DK11170436.7T DK11170436T DK2397136T3 DK 2397136 T3 DK2397136 T3 DK 2397136T3 DK 11170436 T DK11170436 T DK 11170436T DK 2397136 T3 DK2397136 T3 DK 2397136T3
Authority
DK
Denmark
Prior art keywords
harpagophytum
composition according
harpagosides
amount
vitamin
Prior art date
Application number
DK11170436.7T
Other languages
English (en)
Inventor
Laetitia Mathez
Original Assignee
Sp2L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sp2L filed Critical Sp2L
Application granted granted Critical
Publication of DK2397136T3 publication Critical patent/DK2397136T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (14)

1. Sammensætning, der omfatter Harpagophytum eller harpagosider og vitamin D, hvori mængden af Harpagophytum er fra 50 til 3000 mg, mængden af harpagosider er fra 1 til 100 mg og mængden af vitamin D er fra 0,5 til 50 pg.
2. Sammensætning ifølge krav 1, hvori Harpagophytum er i form af pulver eller i form af ekstrakt.
3. Sammensætning ifølge krav 1 eller 2, der omfatter fra 100 til 3000 mg Harpagophytumpulver.
4. Sammensætning ifølge krav 1 eller 2, der omfatter fra 50 til 500 mg Harpagophytumekstrakt, der indeholder 10 til 40 % harpagosider.
5. Sammensætning ifølge krav 1 eller 2, der omfatter fra 50 til 3000 mg Harpagophytumekstrakt, der indeholder 0,5 til 5 % harpagosider.
6. Sammensætning ifølge et hvilket som helst af kravene 1 til 5, der omfatter Harpagophytumpulver i en mængde af 2400 mg, eller et Harpagophytumekstrakt med 20 % harpagosider i en mængde af 200 mg eller harpagosider i en mængde af 40 mg og vitamin D i en mængde af 5 pg.
7. Sammensætning ifølge et hvilket som helst af kravene 1 til 5, der omfatter Harpagophytumpulver i en mængde af 1000 mg, eller et Harpagophytumekstrakt med 0,5 % harpagosider i en mængde af 250 mg eller harpagosider i en mængde af 1,25 mg og vitamin D i en mængde af 5 pg.
8. Sammensætning ifølge et hvilket som helst af kravene 1 til 7, hvori vitamin D er i form af ergocalciferol, cholecalciferol eller en blanding af begge.
9. Sammensætning ifølge et hvilket som helst af kravene 1 til 8, der endvidere omfatter calcium.
10. Sammensætning ifølge et hvilket som helst af kravene 1 til 9, i form af et fødevareprodukt, en drikkevare, et kosttilskud, et nutraceutisk produkt eller en funktionel fødevare, et kosmetisk produkt, et dyrefoderprodukt eller et lægemiddel.
11. Sammensætning ifølge et hvilket som helst af kravene 1 til 10 i form af granuler, tabletter, kapsler, gelkapsler, opløsning, suspension, sirup, pulver, pasta, gel eller creme.
12. Sammensætning ifølge et hvilket som helst af kravene 1 til 11 til anvendelse i forebyggelse og/eller behandling af inflammation eller inflammationssygdomme.
13. Sammensætning til anvendelse ifølge krav 12 til forebyggelse og/eller behandling af inflammationsinduceret smerte.
14. Sammensætning til anvendelse ifølge krav 12 til forebyggelse og/eller behandling degenerative ledsygdomme, navnlig artrose.
DK11170436.7T 2010-06-17 2011-06-17 Antiinflammatorisk sammensætning DK2397136T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1054807A FR2961401B1 (fr) 2010-06-17 2010-06-17 Composition anti-inflammatoire

Publications (1)

Publication Number Publication Date
DK2397136T3 true DK2397136T3 (da) 2018-07-16

Family

ID=43466704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11170436.7T DK2397136T3 (da) 2010-06-17 2011-06-17 Antiinflammatorisk sammensætning

Country Status (7)

Country Link
EP (1) EP2397136B1 (da)
DK (1) DK2397136T3 (da)
ES (1) ES2674874T3 (da)
FR (1) FR2961401B1 (da)
HU (1) HUE038924T2 (da)
PL (1) PL2397136T3 (da)
PT (1) PT2397136T (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210120859A1 (en) * 2019-10-23 2021-04-29 Ivolution Organic Whole Foods Inc. Fortified plant-based formulations

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2496469C2 (ru) * 2012-01-11 2013-10-27 Владимир Николаевич Иванов Безабразивная зубная паста, содержащая фермент папаин, экстракт сфагнума, натрий-кальциевую соль сополимера полиметилвинилового спирта и малеиновой кислоты, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид
ITRM20130501A1 (it) * 2013-09-10 2015-03-11 Aboca Spa Societa Agricola Nuovi estratti di artiglio del diavolo e loro usi.
FR3026643B1 (fr) * 2014-10-02 2018-03-09 Biodevas Laboratoires Aliment complementaire a base d'extraits de plantes aromatiques pour la gestion de la dermatite digitee ou mortellaro par la gestion du stress abiotique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614791B1 (fr) * 1987-05-07 1989-07-21 Moati Roger Association medicamenteuse a base de plantes et oligoelements pour le traitement de rhumatismes et etats inflammatoires
US5888514A (en) * 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation
GB2335919A (en) * 1998-04-01 1999-10-06 Essential Nutrition Ltd A method of producing high anti-inflammatory activity extracts from harpagophytum procumbens
KR100416842B1 (ko) * 2000-11-29 2004-02-05 신준식 하르파지드관련 화합물을 유효성분으로 함유하는 골다공증 예방과 치료용 약학적 조성물
FR2829692B1 (fr) 2001-09-17 2004-10-15 Lehning Lab Composition selective de six categories de substances preservant l'equilibre physiologique chez l'homme comprenant un complexe de micronutriments,un complexe d'antioxydants et un complexe d'acides gras.
EP1371372A1 (de) * 2002-06-08 2003-12-17 Cognis Iberia, S.L. Verwendung von Wirkstoffgemischen enthaltend Tocopherole und Extrakte des Harpagophytum procumbens zur Herstellung eines Medikamentes gegen rheumatische Arthritis
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
DE102005005086A1 (de) * 2005-02-03 2006-08-10 Flavin-Koenig, Dana F., Dr. Naturheilmittel-Nahrungsergänzungs-Kombinationspräparat
CA2550753A1 (en) * 2006-06-21 2007-12-21 A Touch Of Love Inc. Liquid vitamin and supplement formulations
FR2915900B1 (fr) 2007-05-07 2012-08-24 Burgundy Nouveau procede de preparation d'extraits purifies d'harpagophytum procumbens.
WO2010037213A1 (en) * 2008-10-02 2010-04-08 Nutriquine N.V. Compositions comprising plant extracts and use thereof for treating inflammation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210120859A1 (en) * 2019-10-23 2021-04-29 Ivolution Organic Whole Foods Inc. Fortified plant-based formulations

Also Published As

Publication number Publication date
FR2961401B1 (fr) 2013-04-05
EP2397136B1 (fr) 2018-03-28
HUE038924T2 (hu) 2018-12-28
FR2961401A1 (fr) 2011-12-23
PT2397136T (pt) 2018-07-02
EP2397136A1 (fr) 2011-12-21
PL2397136T3 (pl) 2018-09-28
ES2674874T3 (es) 2018-07-04

Similar Documents

Publication Publication Date Title
EP1993528A2 (en) Treatment modalities for autoimmune diseases
WO2012157978A2 (ko) 팥꽃나무 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 아토피 예방 또는 치료용 약학적 조성물
US20190070129A1 (en) Composition comprising panduratin or fingerroot (boesenbergia pandurata) extract for treating, preventing, or ameliorating bone loss disease
CN114126604A (zh) 用于制备包含十六烷化脂肪酸的组合物的方法
ES2674874T3 (es) Composición antiinflamatoria
US20080175888A1 (en) Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
JP7445689B2 (ja) 脂肪分解促進剤
KR20250043587A (ko) 포만감 및/또는 식욕에 관여하는 펩티드 수준의 조절을 통한 체중 조절용 조성물
TW201943413A (zh) 含薑黃酮醇a及／或薑黃酮醇b之組合物
JP2011195530A (ja) タンパク質糖化抑制剤
JP4325908B2 (ja) 脂肪分解促進剤ならびにそれを用いた皮膚外用剤および飲食物
JP2012131760A (ja) 脂肪酸吸収抑制剤
JP6835396B2 (ja) 血中グルコース濃度低減用、血中ヘモグロビンＡ１ｃ量低減用又は血中ＨＤＬ−コレステロール量増加用組成物
JP6709001B1 (ja) ＴＮＦ−α又はＩＬ−６産生抑制用組成物
KR101695299B1 (ko) 필발 추출물, 이소플라본을 함유하는 대두 추출물 및 ｌ-카르니틴을 함유하는 비만 또는 고지혈증 예방용 또는 개선용 조성물
KR20180075423A (ko) 알룰로스를 포함하는, 식물성 유지의 생체 외 배출 촉진용 조성물
JP6547183B2 (ja) トリテルペンを有効成分として含有する変形性関節症の予防又は治療の為の組成物
JP4666736B2 (ja) 高血圧症予防・改善・治療剤
JP2016050202A (ja) ラクトビオン酸を含有する抗ストレス用または恒常性維持用組成物
WO2021106857A1 (ja) 尿意ストレス予防または緩和用組成物及び睡眠改善用組成物
JP2021120358A (ja) 経口皮膚バリア機能向上剤
JP7809777B2 (ja) アレルギー疾患抑制用組成物
KR102607716B1 (ko) 개똥쑥 추출물 또는 아르테미시닌을 유효성분으로 포함하는 일주기 리듬 장애 예방 또는 개선을 위한 조성물
KR20250131910A (ko) 헴프 추출물 및 해파리 가수분해물의 혼합물을 유효성분으로 함유하는 항염증 및 피부 재생용 조성물
JP2024167733A (ja) アンジオテンシンｉｉ１型受容体阻害剤、血圧降下剤並びに高血圧症の予防及び／又は改善剤